AE4 is a DIDS-sensitive Clminus /HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchanger in the basolateral membrane of the renal CCD and the SMG duct

Shigeru B. H. Ko1, Xiang Luo1, Henrik Hager2, Alexandra Rojek2, Joo Young Choi1, Christoph Licht3, Makoto Suzuki4, Shmuel Muallem1, Søren Nielsen2, and Kenichi Ishibashi4

1 Department of Physiology and 3 Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical Center, Dallas, Texas 75390; 2 Department of Cell Biology, Institute of Anatomy, University of Aarhus, DK 8000 Denmark; and 4 Department of Pharmacology, Jichi Medical School, Minamikawachi, 329-0498 Tochigi, Japan


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

The renal cortical collecting duct (CCD) plays an important role in systemic acid-base homeostasis. The beta -intercalated cells secrete most of the HCO<UP><SUB>3</SUB><SUP>−</SUP></UP>, which is mediated by a luminal, DIDS-insensitive, Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange. The identity of the luminal exchanger is a matter of debate. Anion exchanger isoform 4 (AE4) cloned from the rabbit kidney was proposed to perform this function (Tsuganezawa H et al. J Biol Chem 276: 8180-8189, 2001). By contrast, it was proposed (Royaux IE et al. Proc Natl Acad Sci USA 98: 4221-4226, 2001) that pendrin accomplishes this function in the mouse CCD. In the present work, we cloned, localized, and characterized the function of the rat AE4. Northern blot and RT-PCR showed high levels of AE4 mRNA in the CCD. Expression in HEK-293 and LLC-PK1 cells showed that AE4 is targeted to the plasma membrane. Measurement of intracellular pH (pHi) revealed that AE4 indeed functions as a Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchanger. However, AE4 activity was inhibited by DIDS. Immunolocalization revealed species-specific expression of AE4. In the rat and mouse CCD and the mouse SMG duct AE4 was in the basolateral membrane. By contrast, in the rabbit, AE4 was in the luminal and lateral membranes. In both, the rat and rabbit CCD AE4 was in alpha -intercalated cells. Importantly, localization of AE4 was not affected by the systemic acid-base status of the rats. Therefore, we conclude that expression and possibly function of AE4 is species specific. In the rat and mouse AE4 functions as a Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchanger in the basolateral membrane of alpha -intercalated cells and may participate in HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> absorption. In the rabbit AE4 may contribute to HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> secretion.

anion exchanger isoform 4; 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid; submandibular gland; alpha -intercalated cells; kidney; cortical collecting duct


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

SYSTEMIC AND TISSUE-SPECIFIC HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> homeostasis is an essential physiological function. The kidney cortical collecting duct (CCD) plays an important role in systemic acid-base homeostasis (22, 23, 30). HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> secretion and absorption by this segment of the nephron is mediated by an intricate array of luminal and basolateral H+/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> transporters residing in selective cells and selective membranes. The CCD is a heterogeneous epithelium consisting of three main cell types: alpha -, beta -, and gamma -intercalated cells (3, 22, 31, 37, 39). The alpha -intercalated cells are characterized by expression of a vacuolar type H+-ATPase pump in the luminal membrane and a Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchanger in the basolateral membrane (3, 11, 37, 39). Immunocytochemical and molecular evidence suggests that at least part of the Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange in the basolateral membrane of these cells is mediated by a splice variant of anion exchanger isoform 1 (AE1) of the SLC4 family of anion exchanger (2). This arrangement allows alpha -intercalated cells to mediate HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> absorption (2, 11, 22, 39). The beta -intercalated cells display the opposite polarity in terms of expression of the H+/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> transporters. The beta -intercalated cells express a Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange activity in the luminal membrane (8, 9, 39). Accordingly, these cells mediate the bulk of HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> secretion by the CCD (22, 23, 30). The gamma -intercalated cells appear to express Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange activity in both membranes (9). The exact role of these cells in acid-base homeostasis is not well understood.

An unresolved and intriguing question is the identity of the protein(s) responsible for Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange activity in the luminal membrane of the beta -intercalated cells. This activity is unique in that it is resistant to inhibition by DIDS, the classic and defining inhibitor of the SLC4 family, AE1-AE3 (2, 12). Very recently, two studies identified members of two families of anion exchangers as the possible proteins (29, 38). The first is a new member of the AE family, named AE4 (38). AE4 was cloned from isolated rabbit beta -intercalated cells and was shown to function as a Na+-independent Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchanger, although it has higher homology to members of the Na+-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter (NBC) family (27, 33) than to the SLC4 family. Important features of AE4 reported in the study of Tsuganezawa et al. (38) are the resistance to DIDS when expressed in Xenopus oocytes and the colocalization of AE4 and peanut lectin in the luminal membrane of the rabbit CCD. Peanut lectin is a marker of the rabbit beta -intercalated cells. These studies were interpreted to suggest that AE4 is the protein responsible for HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> secretion by beta -intercalated cells.

A different view emerged from examination of HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> secretion in the PDS-/- mouse CCD (29). The PDS gene codes for pendrin, a protein mutated in Pendred syndrome (10). Pendrin belongs to a new family of proteins named SLC26 (20). Members of this family, including pendrin (34), were shown to function as Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchangers (24). In the mouse and human kidney, pendrin is expressed exclusively in the luminal membrane of the CCD (18, 29). Most notably, deletion of the PDS gene eliminated net HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> secretion by isolated, perfused CCD. In fact, the perfused CCD from PDS-/- mice absorbed, rather than secreted, HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> under the same condition that CCD from wild-type mice secreted HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> (29). These findings provide strong evidence that pendrin mediates most, if not all, of the HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> secretion by the CCD, at least in the mouse.

The findings with the PDS-/- mouse (29) raise the question of the role of AE4 in acid-base transport by the kidney and other cells. An organ that absorbs HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> at the resting state and secretes copious amounts of HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> at the stimulated state is the salivary duct (21). Therefore, it was of interest to determine the localization of AE4 in submandibular gland (SMG) duct cell. We independently cloned AE4 from a rat kidney library at the time that the report on the rabbit AE4 appeared. Here we report the functional properties and localization of the AE4 cloned from the rat kidney. Although we also find that AE4 functions as a Na+-independent Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchanger and is expressed mostly in the CCD, our findings reveal three fundamental differences from those reported in the rabbit CCD (38). We find that AE4 activity is completely inhibited by DIDS, and AE4 is expressed in the rat and rabbit alpha -intercalated cells. Membrane localization of AE4 proved to be species specific. In the rat, AE4 is expressed in the basolateral membrane, whereas in the rabbit it was found in the luminal and lateral membrane. Importantly, the localization of AE4 was not influenced by the metabolic status of the animals. We conclude that in the rat AE4 is likely to function in HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> absorption by alpha -intercalated cells.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Cloning of AE4. A human expressed sequence tag (EST) clone (GenBank accession no. AI183992 from testis) was identified by a BLAST search using the NBC family as queries. The EST clone was purchased from Research Genetics (Huntsville, AL) and sequenced to confirm its identity as a new member of the NBC family. A rat kidney cDNA library (14) was screened using the EST clone as probe, and eight clones were obtained. All the clones were sequenced and found to derive from the same gene. The longest clone (3.2 kb) was chosen for further analysis.

Northern blot and RT-PCR analyses. Total RNA was isolated from rat tissues with an RNeasy kit (Qiagen) according to the manufacturer's instructions. Each lane was loaded with 10 µg RNA, which was separated in a 0.8% agarose gel and transferred to nylon membranes. A multiple rat tissue Northern blot containing 2 µg of poly(A) RNA (Clontech) was also probed. The membranes were hybridized with randomly primed full-length AE4 cDNA labeled with [32P]dCTP for 3 h at 68°C in an ExpressHyb hybridization buffer (Clontech). Subsequently, the membranes were washed at high stringency and developed by radiography. Nephron segments were microdissected from the rat kidney and used to prepare mRNA. The mRNA was reverse transcribed with random primers as previously described (25). The synthesized cDNA was used for 30 cycles of PCR (94°C for 1 min, 60°C for 1 min, 72°C for 2 min) with specific primers for AE4: sense AGGCTTCTCGTGATGAGG (nucleotides 512-564) and antisense strand AATCGCTGGGGTACCAGC (nucleotides 1155-1138) with an expected product size of 609 bp. The PCR products were electrophoresed on 2% agarose gels and transferred to nylon membranes, which were hybridized at high stringency. The PCR product obtained from the CCD was subcloned into a plasmid using a TA cloning kit (Invitrogen) and sequenced.

Western blot. Anti-AE4 antibodies were raised against two peptide sequences [antibody A against QPKAPEINISVN, amino acids (aa) 948-959; and antibody B against EEEKTIPENRPEPEH, aa 919-933], at or near the carboxy terminus of AE4. Multiple antigenic peptides (35) were synthesized to generate polyclonal antibodies specific for AE4 by immunizing rabbits. The antisera with the highest titer in an ELISA assay (1:64,000) were IgG fractionated by an affinity column (HiTrap Protein G, Pharmacia Biotech). The IgG fractions were used for Western blots and immunolocalization. For Western blot, membrane vesicles were prepared from the cortex and medulla of the rat kidney by differential centrifugation as before (15). The pellet was suspended in homogenization buffer, and 10 µg of protein were separated by SDS-PAGE. The primary antibodies were used at a dilution of 1:1,000 and the secondary antibody at a dilution of 1:1,000. To verify the specificity of the antibodies, membranes were prepared from HEK-293 cells transfected with green fluorescent protein (GFP) only or GFP and AE4 plasmids. After transfer, the membranes were probed with each of the anti-AE4 antibodies.

Immunostaining of AE4 expressed in HEK-293 and LLC-PK1 cells. Both cell types were plated on glass coverslips and grown in DMEM-high glucose (HG) medium supplemented with 10% fetal calf serum. The cells were transfected with AE4 using the Lipofectamine reagent and grown to confluency to allow development of cell-cell contacts and, in the case of LLC-PK1 cells, to allow establishment of cell polarity. Between 48 and 72 h posttransfection the cells were fixed with 4% formalin for 5 min, washed, and permeabilized by incubation in cold ethanol. The cells were stained with a 1:1,000 dilution of the anti-AE4 antibodies and detected by a 1:400 dilution of a secondary goat anti-rabbit antibody tagged with Alexa 488, as detailed below for rat kidney sections. The cells were imaged by confocal microscopy.

Immunohistochemistry of rat kidney and mouse kidney and SMG. When used, anti-H+ pump antibody was the monoclonal E11 raised against the 31-kDa subunit of the vacuolar H+-ATPase (gift from Dr. S. Gluck). Rat kidneys were fixed by retrograde perfusion via the aorta with 3% paraformaldehyde, in 0.1 M cacodylate buffer, pH 7.4. Mouse kidneys and SMG were removed into an OCT reagent, frozen in liquid N2, and stored at -80°C until sectioning. Immunostaining of mouse kidney and SMG sections was exactly as described (21). When the effect of the metabolic status of the rats on the localization of AE4 was examined, sections from kidneys of control, acidotic, and alkalotic rats were processed in the same manner as mouse tissue (21). For other forms of immunofluorescence microscopy, rat kidney blocks containing all kidney zones were dehydrated and embedded in paraffin. For light- and laser confocal microscopy the paraffin-embedded tissue was cut at 2 µm on a microtome (Leica). The sections were dewaxed and rehydrated. To reveal antigens, sections were put in 1 mM Tris solution (pH 9.0) supplemented with 0.5 mM EGTA and were heated using a microwave oven for 10 min. Nonspecific binding of immunoglobulin was prevented by incubating the sections in 50 mM NH4Cl for 30 min, followed by blocking in PBS supplemented with 1% BSA, 0.05% saponin, and 0.2% gelatin. Sections from all animals and tissues were incubated overnight at 4°C with primary antibodies diluted in PBS supplemented with 0.1% BSA and 0.3% Triton X-100. The sections were then rinsed with PBS supplemented with 0.1% BSA, 0.05% saponin, and 0.2% gelatin for 3 × 10 min. The sections for laser confocal microscopy were incubated in Alexa 488-conjugated goat anti-rabbit antibody (Molecular Probes) diluted in PBS supplemented with 0.1% BSA and 0.3% Triton X-100 for 60 min at room temperature. For double labeling, Alexa 546-conjugated goat anti-mouse antibody (Molecular Probes) was added as well. After rinsing with PBS for 3 × 10 min, the sections were mounted in glycerol supplemented with antifade reagent (N-propyl gallate). The microscopy was carried out using a Leica DMRE light microscope, a Zeiss LSM510, or a Bio-Rad 1024 laser confocal microscope.

Functional expression of AE4 in HEK-293 cells. The full-length AE4 cDNA was subcloned into a mammalian expression vector under the CMV promoter (pCMV-SPORT, GIBCO BRL). HEK-293 cells were cultured in DMEM-HG media supplemented with 10% fetal calf serum and plated on glass coverslips. Two plasmids, one carrying AE4 and one carrying GFP, were transfected using the Lipofectamine reagent (GIBCO BRL) according to instructions provided by the manufacturer and using 1.5 µg of each plasmid. GFP was used to identify the transfected cells. The cells were used for intracellular pH (pHi) measurements 48-72 h posttransfection.

Measurement of pHi. pHi was measured with the aid of BCECF, as detailed (19). In brief, coverslips with cells attached to them were assembled to form the bottom of a perfusion chamber. The cells were perfused with solution containing (in mM) 140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, and 10 HEPES (pH 7.4 with NaOH) and loaded with 2.5 µM BCECF-AM by a 10-min incubation at room temperature. The level of AE4 transfection was estimated from GFP fluorescence. BCECF fluorescence was at least 10-fold higher than the original GFP fluorescence. After BCECF loading, the cells were perfused with a HCO<UP><SUB>3</SUB><SUP>−</SUP></UP>-buffered solution, and pHi was measured by photon counting using a PTI recording setup (Delta Ram, New Brunswick, NJ). The HCO<UP><SUB>3</SUB><SUP>−</SUP></UP>-buffered solution contained (in mM) 120 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose, 5 HEPES, and 25 NaHCO3 (pH 7.4 with NaOH) and was continuously gassed with 95% O2-5% CO2. Na+-free solution was prepared by replacing Na+ with N-methyl-D-glucamine, and Cl--free solution was prepared by replacing Cl- with gluconate. High-K+ solutions were prepared by replacing between 100 and 140 mM NaCl with KCl. BCECF fluorescence was recorded from two to four cells, all of which expressed GFP and at excitation wavelengths of 490 and 440 nm at a resolution of 2/s (19). As reported before for CFTR (19), the correlation between expression of GFP and AE4 activity was close to 100%.

Manipulation of acid-base status of rats. Experiments were with male Sprague-Dawley rats weighing 250-300 g. The animals were allowed free access to food and drinking solution up to the time of the experiments. In each series, a group of experimental animals was compared directly with controls that were obtained from the same shipment and studied during the same period. Chronic metabolic acidotic (CMA) rats were obtained by following the procedure described in Ref. 5. Control and CMA rats were allowed to drink water or water supplemented with 0.28 M NH4Cl for 7 days, respectively. Both groups received standard rat chow ad libitum. On the day of the experiment, rats were anesthetized with pentobarbital sodium. Blood was collected by aortic puncture for analysis of plasma pH, and the kidneys were rapidly removed and embedded in the OCT compound for obtaining frozen sections or immersed in 10% formaldehyde solution for further analysis. The blood pH of control rats was 7.411 and 7.466 (n = 2). The blood pH of CMA rats was 7.306 and 7.343 (n = 2), respectively. To obtain alkalotic rats, animals were placed in metabolic cages and allowed to acclimate on a synthetic diet consisting of (in g) 180 casein, 200 cornstarch, 500 sucrose, 35 corn oil, 35 peanut oil, 10 CaHPO4, 6 MgSO4, 5.25 NaCl, 8.3 K2HPO4, and 10 vitamin fortification mixture (ICN, Cleveland, OH) for 5 days. NaCl was then replaced with 7.55 g NaHCO3 for chronic alkali feeding. Subsequently, control rats receiving the synthetic diet were pair fed with rats receiving the synthetic alkali diet. Rats were estimated to receive 6 mmol · kg body wt-1 · day-1 NaCl or NaHCO3. In this protocol Na ingestion by control and experimental animals is the same. Serum HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> concentration in control rats averaged 26.1 ± 0.76 mM, and in alkalotic rats it averaged 30.48 ± 0.29 mM. Animals were killed after 7 days, and the kidneys were removed and embedded in OCT and processed as described above.


    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

Characterization of AE4 cDNA and predicted protein. The AE4 cDNA cloned from the rat kidney has a composite nucleotide sequence of 3,178 bp and encodes a protein of 953 amino acids with a predicted molecular mass of 105 kDa (GenBank/EBI/DDBJ Data Bank, accession no. AB024339) (Fig. 1A). Hydropathy analysis (Kyte-Doolittle algorithm) of the predicted sequence suggests that AE4 has 12 putative membrane-spanning segments. It has four potential NH2-linked glycosylation sites (Asn-546, Asn-570, Asn-932, and Asn-949, but only Asn-546 and Asn-570 are predicted as extracellular). The NH2 terminus has a leucine-zipper motif (LQKLRGLLAEGIVLLDCPARSL, aa Leu-101 to Leu-126), which may mediate protein-protein interaction. Three putative protein kinase A phosphorylation sites (Ser-173, Ser-273, and Ser-764, with Ser-173 and Ser-273 predicted to be intracellular), six protein kinase C phosphorylation sites (with Thr-71, Thr-252, Ser-268, and Thr-352 predicted intracellular and Thr-655 and Ser-759 predicted extracellular), and 10 casein kinase II phosphorylation sites (Ser-31, Ser-37, Ser-121, Ser-173, Ser-248, Ser-548, Thr-593, Ser-900, Thr-917, and Ser-930, with only Ser-548 and Thr-593 predicted to be extracellular) can be identified in the sequence.


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 1.   Sequence alignment of anion exchanger isoform 4 (AE4) and phylogenic tree of mammalian HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> transporters. A: sequence alignments of AE4 from rat (rAE4; GenBank accession no. AB024339), rabbit (rabAE4; AB038263), and human (hAE4; AB032762). The putative transmembrane (TM) domains predicted by Kyte-Doolittle algorithm are underlined with a solid line and marked TM1-TM12. The putative DIDS binding motifs are in black boxes. Double underline represents peptide sequence used to raise the antibodies. B: phylogenic tree was constructed according to Higgins' method (13a). The length of the horizontal lines indicates the degree of amino acid divergence. For most transporters rat sequences were used. For NDCBE1, NCBE, NBC4, and BTR1 the human sequences were used because the rat sequences for these transporters are not available at present. GenBank accession nos.: rAE1, P23562; rAE2, A34911; rAE3, A42497; rAE4, AB024339; rNBC1, AF004017; rNBC2, AF070475; NDCBE1, AF069512; NCBE, AB040457; and BTR1, AF336127.

A human ortholog of rat AE4 was obtained from the genome sequence database. The human AE4 is Homo sapiens clone CTC-329D1 and is located in chromosome 5 (accession no. AC008438). The deduced amino acid sequences of human and rabbit AE4 are aligned with rat AE4 in Fig. 1A. The coding sequence of human AE4 is composed of 21 exons. Rat AE4 has 80% identity with the rabbit AE4 (38). Human AE4 is longer than rat AE4 by three amino acids (26). The predicted protein sequence of rat and human AE4 shows 78% identity. Comparison of amino acid sequences of rat AE4 with that of members of the superfamily of the HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> transporters is shown in Fig. 1B. AE4 has 47, 42, and 39% amino acid identity with the HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> transporters human NBC2 (16), Drosophila Na+-driven anion exchanger (NDAE1) (28), and mouse brain AE3 (17), respectively. The amino acid sequence in the putative transmembrane regions is well conserved between AE4 and members of the HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> transporter superfamily, while the intracellular NH2- and carboxyl-terminal regions are divergent. Importantly, the putative DIDS binding motif KMLN is present in AE4 (Fig. 1A). This motif was identified by sequence analysis of members of the SLC4 family and by biochemical labeling of AE1 as KL(X)K and later expanded on the basis of sequence analysis of the electrogenic NBCs to K-(Y)(X)-K where Y = M,L and X = I,V,Y (27). A second potential DIDS binding motif (RLQK) is present between TM7 and TM8. Presence of available lysines in such motifs allows for the possibility of inhibition of AE4 by DIDS.

Expression profile of AE4 in rat tissues. Northern blot analysis revealed the presence of a prominent 3.4-kb AE4 mRNA in the kidney (Fig. 2A) and gastrointestinal (GI) tract (Fig. 2B), which was absent or below detection levels in all other tissues examined. A higher molecular weight mRNA of lower intensity was present in the kidney (Fig. 2A). Expression of AE4 mRNA in the kidney and GI tract was further analyzed by subdividing the kidney into segments and using various tissues of the GI tracts (Fig. 2B). High levels of AE4 mRNA were found in the cortex with diminished amount in the outer medulla and absence from the inner medulla. Interestingly, high level of AE4 mRNA was also expressed in the cecum, but it was absent in other segments of GI tracts. To localize mRNA expression more precisely, we performed RT-PCR analysis with mRNA prepared from microdissected nephron segments. Figure 2C shows that AE4 mRNA is expressed at high levels in the CCD.


View larger version (69K):
[in this window]
[in a new window]
 
Fig. 2.   Northern blot analysis, RT-PCR, and Western blot analysis of AE4. A: Clontech membrane with poly(A) RNA from multiple rat tissues was hybridized with randomly primed full-length AE4 cDNA. Ht, heart; Br, brain; Sp, spleen; Lg, lung; Lv, liver; Ms, muscle; Kd, kidney; Te, testes. B: Northern blot analysis of total RNA prepared from rat tissues and hybridized as in A. Nos. indicate preparation of mRNA from stomach (1), jejunum (2), ileum (3), cecum (4), colon (5), pancreas (6), renal cortex (7), renal outer medulla (8), and renal inner medulla (9). C: primers listed in EXPERIMENTAL PROCEDURES were used to amplify AE4 mRNA by RT-PCR from microdissected nephron segments, and the result of a Southern blot with the AE4 probe is shown. Arrow-marked probe indicates migration of probe amplified from the cDNA. The segments used are glomeruli (GL), proximal convoluted tubule (PCT), proximal striated tubule (PST), thick ascending limb of the loop of Henle (TAL), and cortical collecting duct (CCD). Identity of product amplified from CCD was verified by sequencing. For Western blots HEK-293 cells were transfected with green fluorescent protein [GFP; control (Con) lane in each blot in D and E] or with AE4. Microsomes were prepared from HEK-293 cells (D and E) or the kidney outer medulla (OM) and cortex (Cx) (F) and were used for SDS-PAGE. For HEK-293 cells, each lane contained ~20 µg protein, and for kidney each lane contained ~10 µg protein. The blots in E and F were probed with anti-AE4 antibodies A, and the blot in D was probed with anti-AE4 antibodies B. The primary antibodies were used at a dilution of 1:1,000 and the secondary antibody at a dilution of 1:1,000. The right blot in F was probed with anti-AE4 antibody A that was preabsorbed with the peptide (10 µg/ml) used to raise the antibodies. The specific 125- to 135-kDa band (arrow) is expressed at higher level in the kidney Cx and at low level in the OM. Note the band at 125- to 135-kDa disappeared as a result of preabsorption of the antibodies with a competing peptide.

Expression of the AE4 protein was verified by Western blot analysis. The results are shown in Fig. 2, D-F. In Fig. 2, D and E, the specificity of the antibodies was determined by their ability to recognize recombinant AE4 expressed in HEK-293 cells. Anti-AE4 antibody B (Fig. 2D) and anti-AE4 antibody A (Fig. 2E) recognized two bands only in cells transfected with AE4. The broad 120- to 150-kDa band probably represents the glycosylated mature AE4, whereas the lower, sharper band is likely the immature protein. Anti-AE4 antibody A was used to detect the protein in kidney microsomes. Figure 2F shows that a protein of 125-135 kDa (arrow) was detected in the kidney cortex and at lower level in the outer medulla. This size probably represents the glycosylated form of AE4 because it was similar to the upper band detected in HEK-293 cells. Figure 2F, right, shows that the 125- to 135-kDa band disappeared by preabsorbing the antibody with a competing peptide. The bands of lower molecular weight are most likely nonspecific, because treating the antibodies with the competing peptide did not eliminate them. The results in Fig. 2 establish the specificity of our anti-AE4 antibodies and indicate that the protein is expressed at the highest level in the kidney cortex.

Functional characterization of AE4. To characterize the activity of AE4 it was necessary to show that the recombinant protein is targeted to the plasma membrane. Therefore, we expressed AE4 in HEK-293 and LLC-PK1 cells and immunolocalized it using the antibody that was used in Fig. 2, E and F. Figure 3, A and B, establishes the specificity of the antibody for immunolocalization. Thus the anti-AE4 antibody A detected the transfected cells (Fig. 3A), and the staining was completely eliminated by preincubation of the antibodies with the blocking peptide (Fig. 3B). The high-magnification images in Fig. 3, C and D, show that in HEK-293 cells AE4 localized largely at the plasma membrane with no noticeable expression in the endoplasmic reticulum (ER) or the Golgi. Figure 3, E and F, shows punctate expression of AE4 in the plasma membrane of LLC-PK1 cells, including at cell-cell contacts. Control experiments with antibodies adsorbed with the antigenic peptide revealed complete absence of labeling (not shown). Targeting of AE4 to the plasma membrane made it possible to use expression of AE4 in HEK-293 cells for functional characterization.


View larger version (87K):
[in this window]
[in a new window]
 
Fig. 3.   Immunolocalization of AE4 expressed in HEK-293 and LLC-PK1 cells. AE4 was transiently expressed in HEK-293 (A-D) or LLC-PK1 cells (E and F). A and B: cells were immunostained with anti-AE4 antibody A (green) and counterstained with 4,6-diamidino-2-phenylindole to label the nuclei. In B the antibodies were preadsorbed with the competing peptide before use for immunostaining. Scale bar, 25 µm. C and D: 2 examples of localization of AE4 to the plasma membrane of HEK-293 cells. Scale bar, 5 µm. E and F: similar targeting to the plasma membrane of LLC-PK1 cells. Scale bar, 5 µm.

Measurement of pHi showed that at the relatively low expression levels of AE4 used in the present work, expression of AE4 had no measurable effect on resting pHi, which averaged 7.29 ± 0.03 (n = 20) and 7.13 ± 0.03 (n = 20) in HEPES- and HCO<UP><SUB>3</SUB><SUP>−</SUP></UP>-buffered media, respectively. Figure 4, A and B, shows that expression of AE4 in HEK-293 cells induced Cl--dependent HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> transport. At the level of expression used for the experiments in Fig. 4, exposing AE4-transfected cells incubated in HEPES-buffered medium to a Cl--free medium had minimal effect on pHi. On the other hand, exposing the cells to Cl--free medium in the presence of HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> caused marked cytosolic alkalinization (Fig. 4B). pHi returned to basal level on returning the cells to medium containing Cl-. At higher expression levels AE4 also showed Cl-/OH- exchange activity (not shown). The cytosolic alkalinization on removal of Cl- and the acidification on readdition of Cl- to the incubation medium were similar in media containing 150 or 5 mM Na+ (Fig. 4C). Incubating the cells with 10 µM ethylisopropyl amiloride (EIPA), a concentration sufficient to inhibit Na+/H+ exchange activity and the activity of the newly discovered novel, luminal Na+-dependent OH-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> transporters (21), did not affect Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange in AE4-expressing cells (Fig. 4D). Depolarizing the cells by incubation in a medium containing 100 mM K+ and 2 µM valinomycin was also without effect on the Cl--dependent changes in pHi (Fig. 4E). Averaging the rates of Delta pHi/min under each condition showed no statistically different effect of any of the conditions on AE4 activity. Hence, the results in Fig. 4 show that AE4 mediates a Na+-independent, Cl--dependent HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> transport that is not affected by high concentration of EIPA and cell depolarization, all typical characteristics of all members of the SLC4 exchangers (3, 7). Similar properties were reported for the rabbit ortholog of AE4 (38).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   Properties of Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange activity in HEK-293 cells expressing AE4. HEK-293 cells were transfected with GFP (A; control). In all other panels (B-E) the cells were cotransfected with GFP and AE4. The cells in A (control) and B (AE4) were incubated in HEPES-buffered media, and, where indicated by bars, the cells were exposed to Cl--free medium. The same protocol was repeated after incubating the cells in HCO<UP><SUB>3</SUB><SUP>−</SUP></UP>-buffered media. In C-E the cells were maintained in HCO<UP><SUB>3</SUB><SUP>−</SUP></UP>-buffered media throughout. In the first portion of each experiment, the cells were transiently incubated in Cl--free medium before exposure to media containing 5 mM Na+ (C), 10 µM ethylisopropyl amiloride (EIPA; D), or 100 mM K+ and 2 µM valinomycin (Val) (E). As indicated by the bars, the cells were exposed to Cl--free media under each of the conditions. Each trace represents 1 of 3 experiments with similar results.

An important characteristic of all members of the SLC4 family is their inhibition by the stilben compound DIDS (2, 7). Two DIDS binding motifs are present in the AE4 sequence. Yet, it was reported that expression of the rabbit AE4 in Xenopus oocytes resulted in DIDS-insensitive Cl- uptake (38). This is a critical point with respect to the possible function of AE4 because the Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange activity in the luminal membrane of beta -intercalated cells is DIDS insensitive (8, 9, 40). Therefore, we carefully examined the effect of 4,4'-diisothiocyanatodihydrostilbene-2,2'-disulfonic acid (H2DIDS) on AE4 activity. Individual examples and the summary of the results are shown in Fig. 5. H2DIDS potently inhibited AE4 activity with 50% inhibition at ~5 µM H2DIDS. We also tested the effect of 200 µM DIDS, which also completely inhibited AE4 activity.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   DIDS inhibits AE4-mediated Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange activity. A: HEK-293 cells transfected with AE4 were incubated in HCO<UP><SUB>3</SUB><SUP>−</SUP></UP>-buffered solutions and in the presence or absence of the indicated concentration of 4,4'-diisothiocyanatodihydrostilbene-2,2'-disulfonic acid (H2DIDS). At the times indicated by the bars, the cells were exposed to Cl--free solutions. B: summary of the results of 4-7 experiments under each H2DIDS concentration between 0 and 200 µM.

Localization of AE4 in the kidney. The RT-PCR analysis in Fig. 2 indicated expression of AE4 mainly in the CCD. We extended this analysis to localize the AE4 in specific regions of the CCD by immunocytochemistry. Figure 6 shows that the anti-AE4 antibody A stained exclusively the basolateral membrane of cells in the CCD. Staining was absent from all other segments of the nephron, including intercalated cells in collecting ducts in the inner stripe of the outer and inner medulla (Fig. 6, D and E). In control experiments preincubation with the peptide used to raise the antibodies eliminated the staining (Fig. 6F). Localization of AE4 in the basolateral membrane of the rat CCD cells (Fig. 6) was unexpected in view of the reported expression of AE4 in the luminal membrane of rabbit CCD beta -intercalated cells (38). As a first protocol to verify basolateral localization of AE4 in the rat CCD we used the anti-AE4 antibody B (see EXPERIMENTAL PROCEDURES and Fig. 2). Figure 6, G and H, shows that anti-AE4 antibody B also stained exclusively the basolateral membrane of the rat CCD.


View larger version (138K):
[in this window]
[in a new window]
 
Fig. 6.   Localization of AE4 in the rat CCD. AE4 was localized in rat kidney cortex (A-C), outer medulla (inner stripe) (D), and inner medulla (E) using anti-AE4 antibody A (serum, 1:6,000). A: survey section showing anti-AE4 labeling in CCD. No labeling of other parts of the nephron was observed. CD, collecting duct; Glo, glomerulus. B and C: AE4 labeling is associated with the basal (large arrows) and lateral (small arrows) plasma membrane, whereas the luminal membrane was unlabeled. P, proximal tubule. D and E: in the inner stripe of the outer medulla and in the inner medulla no labeling was observed. F: control using anti-AE4 antibody preabsorbed with immunizing peptide (in all cases 0.1 mg/ml) shows no labeling. G and H: localization of AE4 in rat kidney cortex using anti-AE4 antibody B (IgG, 1:15,000). G: as with antibody A, the labeling with anti-AE4 antibody B was associated with the basal (large arrows) and lateral (small arrows) plasma membrane. H: control using anti-AE4 antibody B preabsorbed with immunizing peptide and showing no labeling. Magnification: A, ×130; B-H, ×360.

One possibility for the discrepancy between the results in the rabbit (38) and the rat (the present work) is that expression of AE4 is species specific. To test this possibility, we compared the staining pattern in the rat, mouse, and rabbit CCD using the same antibodies and staining procedure. To allow the use of the polyclonal antibodies in rabbit, the anti-AE4 antibody was biotinylated. Figure 7, A and B, shows that the anti-AE4 antibody A specifically stained the lateral and luminal membranes of the rabbit CCD. In Figure 7C, we identified the cells in the rabbit CCD as alpha -intercalated cells because they also expressed the vacuolar H+ pump in the luminal membrane. Only alpha -intercalated cells express the H+ pump in the luminal membrane (3, 11, 22, 30, 31, 37, 39). Finally, the biotinylated anti-AE4 antibodies stained the basolateral membrane of the rat CCD as was found with the nonbiotinylated antibodies (Fig. 7D). In Fig. 8 the rat kidney was double-stained with anti-AE4 and anti-H+ pump antibodies to identify the cells expressing AE4 in the basolateral membrane. Figure 8, A and B, and Fig. 8, C and D, respectively, show that both alpha -intercalated cells and beta -intercalated cells in the rat CCD express AE4 only in the basolateral membrane.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 7.   Laser-confocal localization of AE4 in collecting ducts in rabbit and rat kidneys. Labeling was with biotinylated anti-AE4 antibody A (affinity purified, 1:200). A: CCD in rabbit kidney showing AE4 labeling in the apical (large arrows) and lateral (small arrows) plasma membrane in the intercalated cells. L, lumen. B: control using anti-AE4 antibody preabsorbed with immunizing peptide (in all cases 0.1 mg/ml) shows no labeling. CD, collecting duct. C: AE4 (green) was present in the apical and lateral plasma membrane of CCD alpha -intercalated cells. alpha -Intercalated cells were identified as the cells expressing the vacuolar H+- ATPase in the apical plasma membrane (red labeling, large arrows). L, lumen. D: in contrast to the rabbit CCD, the rat CCD showed basal (large arrows) and lateral (small arrows) labeling using the same antibody as in A-C. Inset: control using biotinylated anti-AE4 antibody preabsorbed with immunizing peptide and showing no labeling. Magnification: A-D, ×600; inset, ×150.



View larger version (28K):
[in this window]
[in a new window]
 
Fig. 8.   Localization of AE4 and the vacuolar H+ pump in rat kidney cortex, outer medulla, and inner stripe of the outer medulla. A and B: AE4 labeling (green) is present in the basolateral (arrows) and absent from the luminal membrane of alpha -intercalated cells in the CCD. alpha -Intercalated cells were identified by expression of the H+ pump in the luminal membrane (red labeling, arrowheads). CD, collecting duct. C and D: AE4 (green) was also observed in the basolateral membrane of beta -intercalated cells (arrows) in the collecting duct. beta -Intercalated cells were identified as cells expressing H+ pump (red) in the basolateral membrane. E and F: little or no AE4 was observed in collecting duct intercalated cells in the inner stripe of the outer medulla. By contrast, these cells exhibit abundant H+ pump (arrowheads). Magnification: A, C, E, and F, ×1,300; B and D, ×650.

To extend the finding in the rat to another species, we used the two anti-AE4 antibodies to localize the protein in mouse tissues. Figure 9, A and B, shows that anti-AE4 antibodies A and B, respectively, labeled the basolateral membrane of the mouse CCD. In the final control, we determined localization of AE4 in another tissue that transports large quantities of HCO<UP><SUB>3</SUB><SUP>−</SUP></UP>, the mouse SMG. Figure 9C shows that the anti-AE4 antibody A localized the protein in the basolateral membrane of the mouse SMG duct.


View larger version (93K):
[in this window]
[in a new window]
 
Fig. 9.   Localization of AE4 in mouse kidneys and submandibular gland (SMG) and lack of effect of the metabolic state of the rats on localization of AE4. Mouse kidneys (A and B) and SMG (C) were stained with anti-AE4 antibody A (A and C) or anti-AE4 antibody B (B). Arrows mark AE4 in the basolateral membrane. In D-F the effect of metabolic acidosis and alkalosis on localization of AE4 in the rat kidney was examined. Kidneys from 2 control (D), 2 acidotic (E), and 4 alkalotic (F) rats were processed for immunolocalization and stained with anti-AE4 antibody A. Note that in all kidneys AE4 was found only in the basolateral membrane of the CCD.

One possibility for the species-specific expression of AE4 is that expression of AE4 is influenced by the metabolic state of the animal. Indeed, up- and downregulation of expression of acid-base transporters in other segments of the nephron are well documented (4, 13). In addition, it was suggested that the CCD is a plastic epithelium capable of targeting expression of the H+ pump and the Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchanger to alternative membrane based on the metabolic state of the animal (1). To examine this possibility we determined the effect of acidosis and alkalosis on localization of AE4 in the rat kidney. Shown in Fig. 9, D-F, are examples of localization of AE4 in the rat CCD of control, acidotic, and alkalotic rats. The similar basolateral membrane localization observed in two control, two acidotic, and four alkalotic rats clearly shows that AE4 localization was not influenced by the metabolic state of the rats.

The results of the present work indicate that the newly discovered member of the SLC4 family, AE4, indeed functions as a Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchanger. However, our findings differ in three ways from a previous report describing the properties of this protein (38). First, we found that AE4-mediated Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange in HEK-293 cells is DIDS sensitive, whereas in a previous study it was suggested that AE4-mediated Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange in Xenopus oocytes is DIDS insensitive (38). The simplest explanation to this discrepancy is that AE4 behaves differently when expressed in mammalian cells and Xenopus oocytes. Other differences between our studies and that in Xenopus oocytes are that in Xenopus oocytes the effect of DIDS was measured on Cl-/Cl- exchange in the absence of HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> rather than Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange in the presence of 100 mM cis Cl-. Second, we find that AE4 is expressed in the basolateral membrane of rat kidney alpha -intercalated cells and the mouse CCD and SMG duct, whereas previous work suggested expression of AE4 in the luminal membrane of rabbit kidney beta -intercalated cells (38). This turned out to be at least in part due to species-specific expression of the protein. Hence, the antibodies used in the present work to localize AE4 in the basolateral membrane of the CCD localized AE4 to the luminal and lateral membranes of the rabbit CCD. The physiological significance of such species-specific localization is not obvious. A naturally more alkaline rabbit diet can explain expression of AE4 in the luminal membrane. However, why such expression exists in alpha -intercalated cells together with the H+ is puzzling. One possibility is that HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> transport itself, not localization of the transporters, in the rabbit CCD is highly responsive to the metabolic state of the rabbit. At acidosis the H+ pump is functional and AE4 is dormant, whereas in alkalosis AE4 is active and the pump is dormant. In such an arrangement, the alpha -intercalated cells aid the beta -intercalated cells in HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> secretion. This speculation remains to be tested experimentally in the rabbit. Such tests in the rat proved to be negative as localization of AE4 in the rat CCD was not affected by the metabolic state of the rats. In addition, we note that Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange by AE4 is DIDS sensitive (Fig. 5), whereas HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> secretion by the CCD is DIDS insensitive (8, 9, 39).

Localization of AE4 in the mouse and rat basolateral membrane of alpha -intercalated cells suggests that the major role of this transporter in these species is mediating HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> efflux during H+ secretion by the CCD. The alpha -intercalated cells of the CCD also express a splice variant of AE1 in the basolateral membrane (2, 3, 12). Identification of mutations in AE1 that leads to distal renal tubular acidosis (6, 32, 36) clearly indicates that AE1 plays an important role in clearance of cytosolic HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> during acid secretion by alpha -intercalated cells. It is, however, possible that AE4 is complementary with AE1 in mediating basolateral HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> efflux in alpha -intercalated cells, and expression of AE4 allows some acid-base regulation in patients with mutations in AE1. Alternatively, expression of AE4 may overlap with that of AE1, and both proteins share the same physiological role. In any case, it is interesting that the function of AE4 and AE1 does not appear to be redundant, although both Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchangers are expressed in the same membrane of the same cell type. Potential parallel function of AE4 and AE1 in the basolateral membrane of the mouse and rat and of pendrin (29) and AE4 in the luminal membrane of the rabbit would suggest that AE4 has a complementary role in acid-base homeostasis, depending on the animal demand. Future studies remain to be done to find out whether AE1 and AE4 have specialized function in the kidney and possibly other organs.


    ACKNOWLEDGEMENTS

We are indebted to Dr. P. Preisig for access to the metabolic cages and for overseeing the preparation of the acidotic and alkalotic rats. We thank E. A. Salam and A. Y. Umpierre for expert assistance in setting the metabolic state of the rats and in determining blood gases and electrolytes, respectively.


    FOOTNOTES

This work was supported by a grant from the Salt Science Foundation to K. Ishibashi and by National Institutes of Health Grant DE-12309 and a grant from the Cystic Fibrosis Foundation to S. Muallem. S. B. H. Ko was supported by a fellowship from the Uehara Memorial Foundation.

Address for reprint requests and other correspondence: S. Muallem, Dept. of Physiology, Univ. of Texas Southwestern Medical Center, Dallas, TX 75390 (E-mail: shmuel.muallem{at}utsouthwestern.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

June 5, 2002;10.1152/ajpcell.00512.2001

Received 25 October 2001; accepted in final form 8 May 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

1.   Al-Awqati, Q. Plasticity in epithelial polarity of renal intercalated cells: targeting of the H+-ATPase and band 3. Am J Physiol Cell Physiol 270: C1571-C1580, 1996[Abstract/Free Full Text].

2.   Alper, SL. The band 3-related anion exchanger (AE) gene family. Annu Rev Physiol 53: 549-564, 1991[ISI][Medline].

3.   Alper, SL, Natale J, Gluck S, Lodish HF, and Brown D. Subtypes of intercalated cells in rat kidney collecting duct defined by antibodies against erythroid band 3 and renal vacuolar H+-ATPase. Proc Natl Acad Sci USA 86: 5429-5433, 1989[Abstract].

4.   Alpern, RJ, Moe OW, and Preisig PA. Chronic regulation of the proximal tubular Na/H antiporter: from HCO3 to SRC. Kidney Int 48: 1386-1396, 1995[ISI][Medline].

5.   Aruga, S, Wehrli S, Kaissling B, Moe OW, Preisig PA, Pajor AM, and Alpern RJ. Chronic metabolic acidosis increases NaDC-1 mRNA and protein abundance in rat kidney. Kidney Int 58: 206-215, 2000[ISI][Medline].

6.   Bruce, LJ, Cope DL, Jones GK, Schofield AE, Burley M, Povey S, Unwin RJ, Wrong O, and Tanner MJ. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest 100: 1693-1707, 1997[Abstract/Free Full Text].

7.   Cabantchik, ZI, and Greger R. Chemical probes for anion transporters of mammalian cell membranes. Am J Physiol Cell Physiol 262: C803-C827, 1992[Abstract/Free Full Text].

8.   Emmons, C. Transport characteristics of the apical anion exchanger of rabbit cortical collecting duct beta -cells. Am J Physiol Renal Physiol 276: F635-F643, 1999[Abstract/Free Full Text].

9.   Emmons, C, and Kurtz I. Functional characterization of three intercalated cell subtypes in the rabbit outer cortical collecting duct. J Clin Invest 93: 417-423, 1994[ISI][Medline].

10.   Everett, LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, and Green ED. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17: 411-422, 1997[ISI][Medline].

11.   Gluck, S, and Nelson R. The role of the V-ATPase in renal epithelial H+ transport. J Exp Biol 172: 205-218, 1992[Free Full Text].

12.   Godinich, MJ, and Jennings ML. Renal chloride-bicarbonate exchangers. Curr Opin Nephrol Hypertens 4: 398-401, 1995[Medline].

13.   Greger, R. Physiology of renal sodium transport. Am J Med Sci 319: 51-62, 2000[ISI][Medline].

13a.   Higgins, DG, Bleasby AJ, and Fuchs R. CLUSTAL V: improved software for multiple sequence alignment. Comput Appl Biosci 8: 189-191, 1992[Abstract].

14.   Ishibashi, K, Sasaki S, Fushimi K, Uchida S, Kuwahara M, Saito H, Furukawa T, Nakajima K, Yamaguchi Y, Gojobori T, and Marumo F. Molecular cloning and expression of a member of the aquaporin family with permeability to glycerol and urea in addition to water expressed at the basolateral membrane of kidney collecting duct cells. Proc Natl Acad Sci USA 91: 6269-6273, 1994[Abstract].

15.   Ishibashi, K, Sasaki S, Fushimi K, Yamamoto T, Kuwahara M, and Marumo F. Immunolocalization and effect of dehydration on AQP3, a basolateral water channel of kidney collecting ducts. Am J Physiol Renal Physiol 272: F235-F241, 1997[Abstract/Free Full Text].

16.   Ishibashi, K, Sasaki S, and Marumo F. Molecular cloning of a new sodium bicarbonate cotransporter cDNA from human retina. Biochem Biophys Res Commun 246: 535-538, 1998[ISI][Medline].

17.   Kopito, RR, Lee BS, Simmons DM, Lindsey AE, Morgans CW, and Schneider K. Regulation of intracellular pH by a neuronal homolog of the erythrocyte anion exchanger. Cell 59: 927-937, 1989[ISI][Medline].

18.   Lacroix, L, Mian C, Caillou B, Talbot M, Filetti S, Schlumberger M, and Bidart JM. Na+/I- symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues. Eur J Endocrinol 144: 297-302, 2001[ISI][Medline].

19.   Lee, MG, Wigley WC, Zeng W, Noel LE, Marino CR, Thomas PJ, and Muallem S. Regulation of Cl-/ HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange by cystic fibrosis transmembrane conductance regulator expressed in NIH 3T3 and HEK 293 cells. J Biol Chem 274: 3414-3421, 1999[Abstract/Free Full Text].

20.   Lohi, H, Kujala M, Kerkela E, Saarialho-Kere U, Kestila M, and Kere J. Mapping of five new putative anion transporter genes in human and characterization of SLC26A6, a candidate gene for pancreatic anion exchanger. Genomics 70: 102-112, 2000[ISI][Medline].

21.   Luo, X, Choi JY, Ko SB, Pushkin A, Kurtz I, Ahn W, Lee MG, and Muallem S. HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> salvage mechanisms in the submandibular gland acinar and duct cells. J Biol Chem 276: 9808-9816, 2001[Abstract/Free Full Text].

22.   Madsen, KM, and Tisher CC. Structural-functional relationship along the distal nephron. Am J Physiol Renal Fluid Electrolyte Physiol 250: F1-F15, 1986[Abstract/Free Full Text].

23.   McKinney, TD, and Burg MB. Bicarbonate transport by rabbit cortical collecting tubules. Effect of acid and alkali loads in vivo on transport in vitro. J Clin Invest 60: 766-768, 1977[ISI][Medline].

24.   Melvin, JE, Park K, Richardson L, Schultheis PJ, and Shull GE. Mouse down-regulated in adenoma (DRA) is an intestinal Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchanger and is upregulated in colon of mice lacking the NHE3 Na+/H+ exchanger. J Biol Chem 274: 22855-22861, 1999[Abstract/Free Full Text].

25.   Owada, A, Nonoguchi H, Terada Y, Marumo F, and Tomita K. Microlocalization and effects of adrenomedullin in nephron segments and in mesangial cells of the rat. Am J Physiol Renal Physiol 272: F691-F697, 1997[Abstract/Free Full Text].

26.   Parker, MD, Ourmozdi EP, and Tanner MJ. Human BTR1, a new bicarbonate transporter superfamily member and human AE4 from kidney. Biochem Biophys Res Commun 282: 1103-1109, 2001[ISI][Medline].

27.   Romero, MF, and Boron WF. Electrogenic Na+/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporters: cloning and physiology. Annu Rev Physiol 61: 699-723, 1999[ISI][Medline].

28.   Romero, MF, Henry D, Nelson S, Harte PJ, Dillon AK, and Sciortino CM. Cloning and characterization of a Na+-driven anion exchanger (NDAE1). A new bicarbonate transporter. J Biol Chem 275: 24552-24559, 2000[Abstract/Free Full Text].

29.   Royaux, IE, Wall SM, Karniski LP, Everett LA, Suzuki K, Knepper MA, and Green ED. Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci USA 98: 4221-4226, 2001[Abstract/Free Full Text].

30.   Schuster, VL. Function and regulation of collecting duct intercalated cells. Annu Rev Physiol 55: 267-288, 1993[ISI][Medline].

31.   Schuster, VL, Bonsib SM, and Jennings ML. Two types of collecting duct mitochondria-rich (intercalated) cells: lectin and band 3 cytochemistry. Am J Physiol Cell Physiol 251: C347-C355, 1986[Abstract/Free Full Text].

32.   Shayakul, C, and Alper SL. Inherited renal tubular acidosis. Curr Opin Nephrol Hypertens 9: 541-546, 2000[ISI][Medline].

33.   Soleimani, M, and Burnham CE. Physiologic and molecular aspects of the Na+:HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter in health and disease processes. Kidney Int 57: 371-384, 2000[ISI][Medline].

34.   Soleimani, M, Greeley T, Petrovic S, Wang Z, Amlal H, Kopp P, and Burnham CE. Pendrin: an apical Cl-/OH-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchanger in the kidney cortex. Am J Physiol Renal Physiol 280: F356-F364, 2001[Abstract/Free Full Text].

35.   Tam, JP. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci USA 85: 5409-5413, 1998.

36.   Tanphaichitr, VS, Sumboonnanonda A, Ideguchi H, Shayakul C, Brugnara C, Takao M, Veerakul G, and Alper SL. Novel AE1 mutations in recessive distal renal tubular acidosis. Loss-of-function is rescued by glycophorin A. J Clin Invest 102: 2173-2179, 1998[Abstract/Free Full Text].

37.   Teng-umnuay, P, Verlander JW, Yuan W, Tisher CC, and Madsen KM. Identification of distinct subpopulations of intercalated cells in the mouse collecting duct. J Am Soc Nephrol 7: 260-274, 1996[Abstract].

38.   Tsuganezawa, H, Kobayashi K, Iyori M, Araki T, Koizumi A, Watanabe S, Kaneko A, Fukao T, Monkawa T, Yoshida T, Kim DK, Kanai Y, Endou H, Hayashi M, and Saruta T. A new member of the HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> transporter superfamily is an apical anion exchanger of beta -intercalated cells in the kidney. J Biol Chem 276: 8180-8189, 2001[Abstract/Free Full Text].

39.   Verlander, JW, Madsen KM, and Tisher CC. Axial distribution of band 3-positive intercalated cells in the collecting duct of control and ammonium chloride-loaded rabbits. Kidney Int 57: S137-S147, 1996.

40.   Weiner, ID, Weill AE, and New AR. Distribution of Cl-/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> exchange and intercalated cells in rabbit cortical collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 267: F952-F964, 1994[Abstract/Free Full Text].


Am J Physiol Cell Physiol 283(4):C1206-C1218
0363-6143/02 $5.00 Copyright © 2002 the American Physiological Society